Viewing StudyNCT02094573



Ignite Creation Date: 2024-05-06 @ 2:39 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02094573
Status: COMPLETED
Last Update Posted: 2021-03-15
First Post: 2014-03-18

Brief Title: A Study to Evaluate the Efficacy of Brigatinib AP26113 in Participants With Anaplastic Lymphoma Kinase ALK-Positive Non-small Cell Lung Cancer NSCLC Previously Treated With Crizotinib
Sponsor:
Organization: Takeda